Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Applied Therapeutics Inc (NASDAQ: APLT) closed at $0.1 up 1.00% from its previous closing price of $0.1. In other words, the price has increased by $1.00 from its previous closing price. On the day, 3.3 million shares were traded. APLT stock price reached its highest trading level at $0.102 during the session, while it also had its lowest trading level at $0.099.
Ratios:
For a deeper understanding of Applied Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 0.96.
On December 03, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $1.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 16 ’25 when Kanter Stacy J. sold 43,000 shares for $0.11 per share. The transaction valued at 4,816 led to the insider holds 65,000 shares of the business.
Stacy J. Kanter bought 43,000 shares of APLT for $9,331 on Dec 16 ’25. On Mar 04 ’25, another insider, Perfetti Riccardo, who serves as the Chief Medical Officer of the company, sold 10,366 shares for $0.44 each. As a result, the insider received 4,561 and left with 890,409 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 14531077 and an Enterprise Value of 5086078. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.53. Its current Enterprise Value per Revenue stands at 5.086 whereas that against EBITDA is -0.051.
Stock Price History:
The Beta on a monthly basis for APLT is 2.08, which has changed by -0.8482549 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $1.50, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is -67.76%, while the 200-Day Moving Average is calculated to be -79.16%.
Shares Statistics:
For the past three months, APLT has traded an average of 13.23M shares per day and 8364510 over the past ten days. A total of 144.30M shares are outstanding, with a floating share count of 133.43M. Insiders hold about 7.54% of the company’s shares, while institutions hold 62.07% stake in the company. Shares short for APLT as of 1767139200 were 6633907 with a Short Ratio of 0.50, compared to 1764288000 on 14646387. Therefore, it implies a Short% of Shares Outstanding of 6633907 and a Short% of Float of 4.63.
Earnings Estimates
Applied Therapeutics Inc (APLT) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.47 and -$0.62 for the fiscal current year, implying an average EPS of -$0.54. EPS for the following year is -$0.4, with 3.0 analysts recommending between -$0.29 and -$0.47.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for APLT’s current fiscal year. The highest revenue estimate was $1M, while the lowest revenue estimate was $1M, resulting in an average revenue estimate of $1M. In the same quarter a year ago, actual revenue was $455k
